Could Albumin Be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barre Syndrome? Reply

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)872-872
Number of pages1
JournalJAMA Neurology
Volume74
Issue number7
DOIs
Publication statusPublished - 2017

Cite this